Table 1.

Patient characteristics

Characteristic
No. of patients		33
Age, years	Median (range)	50 (36–73)
Ethnic origin, n (%)	Caucasian	30 (91)
	East/Southeast Asian	2 (6)
	Hispanic	1 (3)
ECOG performance status, n (%)	0	11 (33)
	1	18 (55)
	2	4 (12)
No. of prior chemotherapy, n (%)	2	6 (18)
	3	9 (27)
	4	11 (33)
	≥5	7 (21)
Prior hormonal therapy, n (%)		23 (70)
Prior immunotherapy, n (%)		21 (64)
Prior radiotherapy, n (%)		29 (88)
HER2-overexpression, n (%)	Yes	22 (67)
	No	10 (30)
	Unknown	1 (3)
LVEF, %	Median (range)	56 (52–73)
CA15.3, kU/L	Median (range)	110 (11–770)

Patient characteristics. LVEF left ventricular ejection fraction, CA cancer antigen